Company Stefalamed Srl with Fiscal Code 33487213
recorded a turnover of 2024 of
82.551,
with a net profit of
26.189
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Stefalamed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
26.664
27.014
29.391
37.097
45.527
47.494
46.924
55.640
71.815
82.551
Total Income - EUR
26.665
27.015
29.391
37.208
45.528
47.495
46.925
55.642
71.817
82.554
Total Expenses - EUR
26.392
21.980
23.678
30.662
32.320
41.452
44.292
46.059
49.589
54.259
Gross Profit/Loss - EUR
272
5.035
5.714
6.546
13.208
6.043
2.634
9.583
22.228
28.295
Net Profit/Loss - EUR
-528
4.765
4.676
6.173
12.753
5.598
2.174
9.110
21.618
26.189
Employees
2
2
2
2
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.6%, from 71.815 euro in the year 2023, to 82.551 euro in 2024.
The Net Profit increased by 4.693 euro, from 21.618 euro in 2023, to 26.189 in the last year.
Check the financial reports for the company - Stefalamed Srl
Financial Rating - STEFALAMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Stefalamed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Stefalamed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Stefalamed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
47.011 euro in 2024 which includes Inventories of
261 euro, Receivables of
461 euro and cash availability of
46.289 euro.
The company's Equity was valued at
26.238 euro, while total Liabilities amounted to
36.914 euro.
Equity increased by 4.693 euro, from 21.666 euro in 2023, to 26.238 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Stefalamed Srl